Inventor

SHIPP MARGARET A

US12 patents

⚠️ This page may combine multiple inventors who share the name “SHIPP MARGARET A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DANA FARBER CANCER INST INC

9 patents

US10844126B2Nov 24, 2020

Anti-galectin-1 (GAL1) monoclonal antibodies and fragments thereof for neutralizing GAL1

DANA FARBER CANCER INST INC1 citations70

US10519238B2Dec 31, 2019

Anti-galectin-1 monoclonal antibodies and fragments thereof

DANA FARBER CANCER INST INC2 citations70

US10456465B2Oct 29, 2019

Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1

DANA FARBER CANCER INST INC1 citations69

US11673956B2Jun 13, 2023

Anti-galectin-1 (Gal1) monoclonal antibodies and fragments thereof for neutralizing Gal1

DANA FARBER CANCER INST INC0 citations60

US11446309B2Sep 20, 2022

Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors

DANA FARBER CANCER INST INC0 citations59

US7112420B2Sep 26, 2006

Lymphoma associated molecules and uses therefor

DANA FARBER CANCER INST INC2 citations59

US7632660B2Dec 15, 2009

Lymphoma associated molecules and uses therefor

DANA FARBER CANCER INST INC0 citations48

US9840708B2Dec 12, 2017

Compositions and methods for the modulation of DNA damage responses using BAL1 and BBAP

DANA FARBER CANCER INST INC0 citations41

US9890429B2Feb 13, 2018

Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer

DANA FARBER CANCER INST INC0 citations36

SHIPP MARGARET A

3 patents

US8968740B2Mar 3, 2015

Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1

SHIPP MARGARET A7 citations79

US9206427B2Dec 8, 2015

Compositions, kits, and methods for the modulation of immune responses using galectin-1

SHIPP MARGARET A4 citations63

US9939428B2Apr 10, 2018

Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1

SHIPP MARGARET A0 citations32